Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity.

Barbaro MR, Cremon C, Morselli-Labate AM, Di Sabatino A, Giuffrida P, Corazza GR, Di Stefano M, Caio G, Latella G, Ciacci C, Fuschi D, Mastroroberto M, Bellacosa L, Stanghellini V, Volta U, Barbara G.

Gut. 2020 Feb 14. pii: gutjnl-2019-319281. doi: 10.1136/gutjnl-2019-319281. [Epub ahead of print]

PMID:
32060130
2.

µ-opioid receptor, β-endorphin, and cannabinoid receptor-2 are increased in the colonic mucosa of irritable bowel syndrome patients.

Dothel G, Chang L, Shih W, Barbaro MR, Cremon C, Stanghellini V, De Ponti F, Mayer EA, Barbara G, Sternini C.

Neurogastroenterol Motil. 2019 Nov;31(11):e13688. doi: 10.1111/nmo.13688. Epub 2019 Jul 23.

PMID:
31336406
3.

Italian nationwide survey of pharmacologic treatments in diverticular disease: Results from the REMAD registry.

Cremon C, Carabotti M, Cuomo R, Pace F, Andreozzi P, Barbaro MR, Annibale B, Barbara G.

United European Gastroenterol J. 2019 Jul;7(6):815-824. doi: 10.1177/2050640619845990. Epub 2019 Apr 20.

4.

Nerve fiber overgrowth in patients with symptomatic diverticular disease.

Barbaro MR, Cremon C, Fuschi D, Scaioli E, Veneziano A, Marasco G, Festi D, Stanghellini V, Barbara G.

Neurogastroenterol Motil. 2019 Sep;31(9):e13575. doi: 10.1111/nmo.13575. Epub 2019 Mar 5.

PMID:
30838745
5.

5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein-coupled receptor D.

Bautzova T, Hockley JRF, Perez-Berezo T, Pujo J, Tranter MM, Desormeaux C, Barbaro MR, Basso L, Le Faouder P, Rolland C, Malapert P, Moqrich A, Eutamene H, Denadai-Souza A, Vergnolle N, Smith ESJ, Hughes DI, Barbara G, Dietrich G, Bulmer DC, Cenac N.

Sci Signal. 2018 Dec 18;11(561). pii: eaal2171. doi: 10.1126/scisignal.aal2171.

6.

Recent advances in understanding non-celiac gluten sensitivity.

Barbaro MR, Cremon C, Stanghellini V, Barbara G.

F1000Res. 2018 Oct 11;7. pii: F1000 Faculty Rev-1631. doi: 10.12688/f1000research.15849.1. eCollection 2018. Review.

7.

Pre- and probiotic overview.

Cremon C, Barbaro MR, Ventura M, Barbara G.

Curr Opin Pharmacol. 2018 Dec;43:87-92. doi: 10.1016/j.coph.2018.08.010. Epub 2018 Sep 13. Review.

PMID:
30219638
8.

Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators.

Barbaro MR, Fuschi D, Cremon C, Carapelle M, Dino P, Marcellini MM, Dothel G, De Ponti F, Stanghellini V, Barbara G.

Neurogastroenterol Motil. 2018 Jun 28:e13388. doi: 10.1111/nmo.13388. [Epub ahead of print]

PMID:
29956419
9.

Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial.

Cremon C, Guglielmetti S, Gargari G, Taverniti V, Castellazzi AM, Valsecchi C, Tagliacarne C, Fiore W, Bellini M, Bertani L, Gambaccini D, Cicala M, Germanà B, Vecchi M, Pagano I, Barbaro MR, Bellacosa L, Stanghellini V, Barbara G.

United European Gastroenterol J. 2018 May;6(4):604-613. doi: 10.1177/2050640617736478. Epub 2017 Oct 8.

10.

Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome.

Gargari G, Taverniti V, Gardana C, Cremon C, Canducci F, Pagano I, Barbaro MR, Bellacosa L, Castellazzi AM, Valsecchi C, Tagliacarne SC, Bellini M, Bertani L, Gambaccini D, Marchi S, Cicala M, Germanà B, Dal Pont E, Vecchi M, Ogliari C, Fiore W, Stanghellini V, Barbara G, Guglielmetti S.

Environ Microbiol. 2018 Sep;20(9):3201-3213. doi: 10.1111/1462-2920.14271. Epub 2018 Sep 24.

11.

Protease-activated receptor 1 is implicated in irritable bowel syndrome mediators-induced signaling to thoracic human sensory neurons.

Desormeaux C, Bautzova T, Garcia-Caraballo S, Rolland C, Barbaro MR, Brierley SM, Barbara G, Vergnolle N, Cenac N.

Pain. 2018 Jul;159(7):1257-1267. doi: 10.1097/j.pain.0000000000001208.

PMID:
29554016
12.

Advancements in drug development for diarrhea-predominant irritable bowel syndrome.

Dothel G, Barbaro MR, Raschi E, Barbara G, De Ponti F.

Expert Opin Investig Drugs. 2018 Mar;27(3):251-263. doi: 10.1080/13543784.2018.1442434. Epub 2018 Feb 22. Review.

PMID:
29451407
13.

Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis.

Bashashati M, Moossavi S, Cremon C, Barbaro MR, Moraveji S, Talmon G, Rezaei N, Hughes PA, Bian ZX, Choi CH, Lee OY, Coëffier M, Chang L, Ohman L, Schmulson MJ, McCallum RW, Simren M, Sharkey KA, Barbara G.

Neurogastroenterol Motil. 2018 Jan;30(1). doi: 10.1111/nmo.13192. Epub 2017 Aug 29. Review.

PMID:
28851005
14.

Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome.

Cremon C, Stanghellini V, Barbaro MR, Cogliandro RF, Bellacosa L, Santos J, Vicario M, Pigrau M, Alonso Cotoner C, Lobo B, Azpiroz F, Bruley des Varannes S, Neunlist M, DeFilippis D, Iuvone T, Petrosino S, Di Marzo V, Barbara G.

Aliment Pharmacol Ther. 2017 Apr;45(7):909-922. doi: 10.1111/apt.13958. Epub 2017 Feb 6.

15.

Diagnostic challenges of symptomatic uncomplicated diverticular disease.

Cremon C, Bellacosa L, Barbaro MR, Cogliandro RF, Stanghellini V, Barbara G.

Minerva Gastroenterol Dietol. 2017 Jun;63(2):119-129. doi: 10.23736/S1121-421X.17.02370-4. Epub 2017 Jan 12. Review.

PMID:
28079347
16.

Treatment of Diverticular Disease With Aminosalicylates: The Evidence.

Barbara G, Cremon C, Barbaro MR, Bellacosa L, Stanghellini V.

J Clin Gastroenterol. 2016 Oct;50 Suppl 1:S60-3. doi: 10.1097/MCG.0000000000000611.

PMID:
27622369
17.

Supernatants of irritable bowel syndrome mucosal biopsies impair human colonic smooth muscle contractility.

Guarino MP, Barbara G, Cicenia A, Altomare A, Barbaro MR, Cocca S, Scirocco A, Cremon C, Emerenziani S, Stanghellini V, Cicala M, Severi C.

Neurogastroenterol Motil. 2017 Feb;29(2). doi: 10.1111/nmo.12928. Epub 2016 Sep 12.

PMID:
27619727
18.

Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease.

Barbara G, Scaioli E, Barbaro MR, Biagi E, Laghi L, Cremon C, Marasco G, Colecchia A, Picone G, Salfi N, Capozzi F, Brigidi P, Festi D.

Gut. 2017 Jul;66(7):1252-1261. doi: 10.1136/gutjnl-2016-312377. Epub 2016 Sep 12.

PMID:
27618836
19.

Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers.

Duranti S, Gaiani F, Mancabelli L, Milani C, Grandi A, Bolchi A, Santoni A, Lugli GA, Ferrario C, Mangifesta M, Viappiani A, Bertoni S, Vivo V, Serafini F, Barbaro MR, Fugazza A, Barbara G, Gioiosa L, Palanza P, Cantoni AM, de'Angelis GL, Barocelli E, de'Angelis N, van Sinderen D, Ventura M, Turroni F.

FEMS Microbiol Ecol. 2016 Dec;92(12). pii: fiw191. doi: 10.1093/femsec/fiw191. Epub 2016 Sep 7.

PMID:
27604252
20.

Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism.

Barbaro MR, Di Sabatino A, Cremon C, Giuffrida P, Fiorentino M, Altimari A, Bellacosa L, Stanghellini V, Barbara G.

Am J Physiol Gastrointest Liver Physiol. 2016 Mar 15;310(6):G439-47. doi: 10.1152/ajpgi.00368.2015. Epub 2016 Jan 7.

21.

AIR12, a b-type cytochrome of the plasma membrane of Arabidopsis thaliana is a negative regulator of resistance against Botrytis cinerea.

Costa A, Barbaro MR, Sicilia F, Preger V, Krieger-Liszkay A, Sparla F, De Lorenzo G, Trost P.

Plant Sci. 2015 Apr;233:32-43. doi: 10.1016/j.plantsci.2015.01.004. Epub 2015 Jan 10.

PMID:
25711811
22.

Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome.

Dothel G, Barbaro MR, Boudin H, Vasina V, Cremon C, Gargano L, Bellacosa L, De Giorgio R, Le Berre-Scoul C, Aubert P, Neunlist M, De Ponti F, Stanghellini V, Barbara G.

Gastroenterology. 2015 May;148(5):1002-1011.e4. doi: 10.1053/j.gastro.2015.01.042. Epub 2015 Feb 2.

PMID:
25655556
23.

Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS.

Di Nardo G, Barbara G, Cucchiara S, Cremon C, Shulman RJ, Isoldi S, Zecchi L, Drago L, Oliva S, Saulle R, Barbaro MR, Stronati L.

Neurogastroenterol Motil. 2014 Feb;26(2):196-204. doi: 10.1111/nmo.12250. Epub 2013 Nov 7.

PMID:
24304324

Supplemental Content

Loading ...
Support Center